These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16410815

  • 1. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
    Esposito S, Porta A, Bojanin J, Gualtieri L, Cesati L, Vismara E, Principi N.
    Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
    [Abstract] [Full Text] [Related]

  • 2. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G, Krepler K, Franz C, Ries E, Maar N, Wedrich A, Rieger A, Dejaco-Ruhswurm I.
    Ocul Immunol Inflamm; 2005 May; 13(2-3):213-8. PubMed ID: 16019681
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 4. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 5. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B, Lisić M, Kniewald T, Ugrinović N, Begovac J.
    Lijec Vjesn; 2005 Jun; 127(5-6):123-8. PubMed ID: 16281473
    [Abstract] [Full Text] [Related]

  • 6. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S, Resino R, Micheloud D, Gurbindo Gutiérrez D, Léon JA, Ramos JT, Ciria L, de José I, Mellado J, Muñoz-Fernández A, Spanish Group of Paediatric HIV Infection.
    Clin Infect Dis; 2006 Mar 15; 42(6):862-9. PubMed ID: 16477566
    [Abstract] [Full Text] [Related]

  • 8. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.
    Pediatrics; 2007 Jul 15; 120(1):100-9. PubMed ID: 17606567
    [Abstract] [Full Text] [Related]

  • 9. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 10. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R.
    Ophthalmic Epidemiol; 2008 Feb 15; 15(4):264-71. PubMed ID: 18780260
    [Abstract] [Full Text] [Related]

  • 11. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
    Guillén S, García San Miguel L, Resino S, Bellón JM, González I, Jiménez de Ory S, Muñoz-Fernández MA, Navarro ML, Gurbindo MD, de José MI, Mellado MJ, Martín-Fontelos P, Gonzalez-Tomé MI, Martinez J, Beceiro J, Roa MA, Ramos JT, Madrid Group for Research on Pediatric HIV Infection.
    HIV Med; 2010 Apr 15; 11(4):245-52. PubMed ID: 20050937
    [Abstract] [Full Text] [Related]

  • 12. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R, Arama V, Paraschiv S, Streinu-Cercel A, Oţelea D, Munteanu D, Iosipenco M, Chiotan C, Benea OE, Mărdărescu M, Rădulescu M, Hristea A, Ungurianu R, Aramă SS, Cercel AS, Călin R, Băicuş C.
    Rom J Intern Med; 2008 Apr 15; 46(4):305-11. PubMed ID: 19480296
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
    Shah SU, Kerkar SP, Pazare AR.
    Br J Ophthalmol; 2009 Jan 15; 93(1):88-90. PubMed ID: 18952644
    [Abstract] [Full Text] [Related]

  • 14. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA.
    Pediatr Infect Dis J; 2007 Apr 15; 26(4):334-8. PubMed ID: 17414398
    [Abstract] [Full Text] [Related]

  • 15. The HIV RNA Levels of Plasma and Ocular Fluids in AIDS Patients with Ophthalmic Infections.
    Hsu WM, Chiou SH, Chen SS, Shyong MP, Ho CK, Chen SJ, Wu CC, Kung SH, Chi CW.
    Ophthalmologica; 2004 Apr 15; 218(5):328-32. PubMed ID: 15334014
    [Abstract] [Full Text] [Related]

  • 16. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
    Cattelan AM, Calabrò ML, De Rossi A, Aversa SM, Barbierato M, Trevenzoli M, Gasperini P, Zanchetta M, Cadrobbi P, Monfardini S, Chieco-Bianchi L.
    Int J Oncol; 2005 Sep 15; 27(3):779-85. PubMed ID: 16077928
    [Abstract] [Full Text] [Related]

  • 17. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F, Mosam A, Henry LN, Chisholm JV, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, Martin JN, Coovadia HM, Scadden DT, Brander C.
    AIDS; 2007 Jun 19; 21(10):1245-52. PubMed ID: 17545700
    [Abstract] [Full Text] [Related]

  • 18. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
    Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ.
    J Allergy Clin Immunol; 2004 Apr 19; 113(4):742-6. PubMed ID: 15100682
    [Abstract] [Full Text] [Related]

  • 19. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG, Soe MM, Nesheim SR, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.
    Pediatrics; 2008 May 19; 121(5):e1229-39. PubMed ID: 18450865
    [Abstract] [Full Text] [Related]

  • 20. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P, Trabaud MA, Pradat P, Lebouché B, Chevallier M, Chevallier P, Zoulim F, Trepo C.
    Clin Infect Dis; 2007 Sep 01; 45(5):624-32. PubMed ID: 17682999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.